New Leaf Venture Partners

Latest statistics and disclosures from New Leaf Venture Partners's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by New Leaf Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for New Leaf Venture Partners

New Leaf Venture Partners holds 11 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arvinas Ord (ARVN) 46.6 $53M 1.3M 41.28
 View chart
Edgewise Therapeutics (EWTX) 24.8 $28M 1.6M 18.24
 View chart
Deciphera Pharmaceuticals 7.9 $9.1M 577k 15.73
 View chart
Crinetics Pharmaceuticals In (CRNX) 5.8 $6.6M 141k 46.81
 View chart
Rallybio Corp (RLYB) 5.3 $6.1M 3.3M 1.85
 View chart
Passage Bio (PASG) 3.0 $3.4M 2.5M 1.35
 View chart
Rocket Pharmaceuticals (RCKT) 2.8 $3.2M 118k 26.94
 View chart
Alector (ALEC) 1.8 $2.0M 340k 6.02
 View chart
Cogent Biosciences (COGT) 1.5 $1.7M 251k 6.72
 View chart
X4 Pharmaceuticals (XFOR) 0.4 $466k 335k 1.39
 View chart
Iterum Therapeutics SHS (ITRM) 0.1 $150k 97k 1.54
 View chart

Past Filings by New Leaf Venture Partners

SEC 13F filings are viewable for New Leaf Venture Partners going back to 2014

View all past filings